» Articles » PMID: 29430463

Comparison of Host Gene Expression Profiles in Spleen Tissues of Genetically Susceptible and Resistant Mice During ECTV Infection

Overview
Journal Biomed Res Int
Publisher Wiley
Date 2018 Feb 13
PMID 29430463
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Ectromelia virus (ECTV), the causative agent of mousepox, has emerged as a valuable model for investigating the host- relationship as it relates to pathogenesis and the immune response. ECTV is a mouse-specific virus and causes high mortality in susceptible mice strains, including BALB/c and C3H, whereas C57BL/6 and 129 strains are resistant to the disease. To understand the host genetic factors in different mouse strains during the ECTV infection, we carried out a microarray analysis of spleen tissues derived from BALB/c and C57BL/6 mice, respectively, at 3 and 10 days after ECTV infection. Differential Expression of Genes (DEGs) analyses revealed distinct differences in the gene profiles of susceptible and resistant mice. The susceptible BALB/c mice generated more DEGs than the resistant C57BL/6 mice. Additionally, gene ontology and KEGG pathway analysis showed the DEGs of susceptible mice were involved in innate immunity, apoptosis, metabolism, and cancer-related pathways, while the DEGs of resistant mice were largely involved in MAPK signaling and leukocyte transendothelial migration. Furthermore, the BALB/c mice showed a strong induction of interferon-induced genes, which, however, were weaker in the C57BL/6 mice. Collectively, the differential transcriptome profiles of susceptible and resistant mouse strains with ECTV infection will be crucial for further uncovering the molecular mechanisms of the host- interaction.

Citing Articles

Modifications of Mitochondrial Network Morphology Affect the MAVS-Dependent Immune Response in L929 Murine Fibroblasts during Ectromelia Virus Infection.

Gregorczyk-Zboroch K, Szulc-Dabrowska L, Pruchniak P, Gierynska M, Mielcarska M, Biernacka Z Pathogens. 2024; 13(9).

PMID: 39338909 PMC: 11434706. DOI: 10.3390/pathogens13090717.


The Viral Protein Poly(A) Polymerase Catalytic Subunit Interacts with Guanylate-Binding Proteins 2 to Antagonize the Antiviral Ability of Targeting Ectromelia Virus.

Gao Z, He X, Chen G, Fang Y, Meng Z, Tian H Int J Mol Sci. 2023; 24(21).

PMID: 37958732 PMC: 10648259. DOI: 10.3390/ijms242115750.


Guanylate-Binding Protein 2 Exerts GTPase-Dependent Anti-Ectromelia Virus Effect.

Gao Z, Meng Z, He X, Chen G, Fang Y, Tian H Microorganisms. 2023; 11(9).

PMID: 37764102 PMC: 10534507. DOI: 10.3390/microorganisms11092258.


Role of cytokines in poxvirus host tropism and adaptation.

Rahman M, McFadden G Curr Opin Virol. 2022; 57:101286.

PMID: 36427482 PMC: 9704024. DOI: 10.1016/j.coviro.2022.101286.


Mouse background genetics in biomedical research: The devil's in the details.

Hay A, Howie H, Gorham J, DAlessandro A, Spitalnik S, Hudson K Transfusion. 2021; 61(10):3017-3025.

PMID: 34480352 PMC: 8627118. DOI: 10.1111/trf.16628.


References
1.
Szulc L, Boratynska A, Martyniszyn L, Niemialtowski M . Antigen presenting and effector cell cluster formation in BALB/c mice during mousepox: model studies*. J Appl Microbiol. 2010; 109(5):1817-28. DOI: 10.1111/j.1365-2672.2010.04813.x. View

2.
Takeshita F, Ishii K . Intracellular DNA sensors in immunity. Curr Opin Immunol. 2008; 20(4):383-8. DOI: 10.1016/j.coi.2008.05.009. View

3.
Samuelsson C, Hausmann J, Lauterbach H, Schmidt M, Akira S, Wagner H . Survival of lethal poxvirus infection in mice depends on TLR9, and therapeutic vaccination provides protection. J Clin Invest. 2008; 118(5):1776-84. PMC: 2289795. DOI: 10.1172/JCI33940. View

4.
Xu R, Rubio D, Roscoe F, Krouse T, Truckenmiller M, Norbury C . Antibody inhibition of a viral type 1 interferon decoy receptor cures a viral disease by restoring interferon signaling in the liver. PLoS Pathog. 2012; 8(1):e1002475. PMC: 3252373. DOI: 10.1371/journal.ppat.1002475. View

5.
Karupiah G, Panchanathan V, Sakala I, Chaudhri G . Genetic resistance to smallpox: lessons from mousepox. Novartis Found Symp. 2007; 281:129-36. DOI: 10.1002/9780470062128.ch11. View